Maha FDA raids at three locations in Vasai, Ayurvedic drugs worth Rs 1.41 crore seized

Published On 2024-07-12 10:15 GMT   |   Update On 2024-07-12 10:15 GMT
Advertisement

Vasai: Food and Drugs Administration (FDA) Maharashtra has conducted raid at three different locations at Vasai, Dist. Palghar and found that M/s Gaharwar Pharma Products Pvt. Ltd. who has obtained licence to manufacture ayurvedic drugs at Haryana, was infact manufacturing drugs at Vasai without obtaining licence for manufacturing of drugs at this place, quoting licence details of Haryana.

It was also understood that the loan licence obtained at Haryana was surrendered to the State Licensing Authority, Directorate of Ayush on 14th May, 2024, still the drugs were getting manufactured thereafter at Vasai under the said licence.

Advertisement
The drugs to be manufactured at Haryana were shown to be sold to M/s Onkar Pharma at Jalandhar, Punjab State, but M/s Onkar Pharma was operating its business at Vasai and was distributing drugs from this place under bills of Jalandhar address. Further few drugs were found with manufacturing address of M/s Gaharwar Pharma Pvt. Ltd. Navghar Vasai, Dist. Palghar, which were shown to manufactured in January 2024, the licence at this place granted to Rushabh Medicines were cancelled in the year 2022.
The value of seized ayurvedic drugs, raw materials, machinaries, packing materials, labels, pouches were around Rs. 1.41 crore.
Recently in March 2024 and in 2021, similar raid was conducted at the firm's sister concern M/s Rushabh Medicine, Indo Industrial Estate No. 1, Navghar Vasai (E) and after finding allopathy drug in the ayurvedic medicines in Government Analyst Report, prosecution was filed in the court of law and their licence was cancelled thereafter.
Further investigation is under progress and suitable legal action would be taken against the said manufacturer after completion of investigation. The ayurvedic drugs in this case were seized by Drugs Inspector Palghar Shri Yogendra Pol, Shri Nitin Aher and Drugs Inspector Thane Shri Kailash Khapekar, who were supported by Assistant Commissioner Shri Prakash Mhanwar, Mukund Donglikar, Deepka Malpure, Rohit Rathod from Thane, Shri Mahesh Gadekar, Umesh Gharote from Palghar and Drugs Inspector from Thane, Palghar and Greater Mumbai Shri Kishor Rajne, Smt. Shubhangi Bhujbal, Shri Nitin Aher, Rakesh Edlawar, Yogendra Pol, Pravin Raut, Smt. Poonam Salgaonkar, Rajshree Shinde, Shri Sunil Gawali, Premdas Sakhre and Kailash Khapekar. The raid was supported by Assistant Commissioner from IB Mumbai Shri V R Ravi and Drugs Inspector from IB Mumbai Shri Shashikant Yadav.
The raid was conducted as per the instructions received from FDA Commissioner Shri Abhimanyu Kale, Dr. Rahul Khade Joint Commissioner FDA Vigilance, Shri Narendra Supe Joint Commissioner FDA Thane and Shri Vijay Jadhav Joint Commissioner FDA Greater Mumbai.

Read also: Another man held over fake medicine racket busted in Nagpur district

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News